Myoinositol and function of peripheral nerves in human diabetics. A controlled clinical trial.
Fifty-nine diabetic patients participated in a double-blind study in order to evaluate the efficiency of myoinositol to improve the function of peripheral nerves. Myoinositol in the amounts given was not able to change motor conduction velocity or vibratory perception threshold. No change in retinopathy and several biochemical parameters was observed.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects*; D010525:Peripheral Nerves / Q000503:physiopathology*
D007294:Inositol